SCHEMBL7050844

SCHEMBL7050844

COc1cc(C(=O)c2cccc(C)c2)c(Oc2c(Br)cc(CC(N)=O)cc2Br)cc1C(C)C

nearest known ligand 0.85

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.85
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
THRA P10827 5/20 0.38
THRB P10828 5/20 0.38
CTNNB1 P35222 1/20 0.38
WNT3A P56704 1/20 0.38
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
LPAR1 Q92633 4/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
ACHE P22303 1/20 0.35
KCNK3 O14649 1/20 0.34
KCNK9 Q9NPC2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5632584 0.92 NR3C1 (1.00) NR3C1THRATHRB
SCHEMBL5630623 0.91 NR3C1 (0.85) NR3C1THRATHRBCTNNB1WNT3A
SCHEMBL7684969 0.88 NR3C1 (0.88) NR3C1THRATHRBCTNNB1WNT3A
SCHEMBL7053031 0.86 NR3C1 (0.83) NR3C1THRATHRBCTNNB1WNT3A
SCHEMBL7050568 0.86 NR3C1 (0.76) NR3C1MEN1KMT2ATHRATHRB
SCHEMBL7055432 0.84 NR3C1 (0.73) NR3C1MEN1KMT2ACTNNB1WNT3A
SCHEMBL5631912 0.84 NR3C1 (0.85) NR3C1THRATHRB
SCHEMBL7052439 0.83 NR3C1 (0.75) NR3C1MEN1KMT2ATHRATHRB
SCHEMBL7054470 0.83 NR3C1 (0.84) NR3C1THRATHRB
SCHEMBL7054870 0.83 NR3C1 (0.81) NR3C1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102739-B1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2003-04-23 EP claimed
US-6492424-B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2002-12-10 US claimed
EP-1102739-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2001-05-30 EP claimed
WO-2000007972-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2000-02-17 WO claimed
EP-1102739-B1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KAROBIO AB (SE) 2003-04-23 EP disclosed
US-6492424-B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders KARO BIO AB (SE) 2002-12-10 US disclosed
EP-1102739-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2001-05-30 EP disclosed
WO-2000007972-A1 GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS KARO BIO AB (SE) 2000-02-17 WO disclosed